polski | english | login
Array|Array|Array|Array|Array|Array

DOI: 10.18544/PEDM-23.03.0089
Pediatr Endocrino Diabetes Metab 2017;23,3:165-168

Difficulties of the therapy in a boy with coexisting type 1 diabetes mellitus and idiopathic thrombocytopenic purpura

Joanna Zarębska, Katarzyna Musioł, Paulina Brożek, Adriana Zybała, Patrycja Szerląg, Grażyna Sobol-Milejska, Przemysława Jarosz-Chobot

Key words

idiopathic thrombocytopenic purpura, type 1 diabetes mellitus, insulin pump, glycocorticoids, side effects of the glucocorticotherapy

Abstract

Idiopathic thrombocytopenic purpura (ITP) is an acquired autoimmune disease, caused by antibodies against platelet glycoproteins, which provoke platelet destruction and inhibit platelet production in bone marrow. Type 1 Diabetes Mellitus (T1DM) is an acquired autoimmune disease in witch beta cells are destroyed by autoantibodies. Patient with T1DM since the age of 6, was treated by intensive functional insulin therapy by insulin pump. At the age of 14,5 he was also diagnosed with ITP. Due to the short effect of immunoglobulin therapy, glucocorticoids were introduced. After 3 months of glucocorticotherapy the platelet count was 46 G/l. Patient developed various adverse effects of glucocorticoids, among others stretch marks covering all surface of his abdomen, buttocks, arms and thighs and raise in the daily requirement of insulin by 200%. Adverse effects of glucocorticotherapy made impossible the therapy by insulin pump and imposed urgent revision of the ITP therapy. Side effects of the glucocorticotherapy can make impossible the treatment by insulin pump of T1DM in children.


Article published in polish language



advanced search »

Article in databases

DOI: 10.18544/PEDM-23.03.0089
PUBMED: view

Similar articles

...

The impact of having siblings – analysis of “hygiene theory” of chronic ...

Growth hormone therapy in a girl with Turner syndrome and diabetes type ...

Transition of young adults with type 1 diabetes mellitus from a pediatri ...

Sugar content in non-alcoholic beverages and dietary recemmendations for ...

Pediatric Endocrinology Diabetes and Metabolism

2018; 24, 2: 51-110
2018; 24, 1: 1-50
2017; 23, 4: 169-222
2017; 23, 3: 117-168
2017; 23, 2: 59-116
2017; 23, 1: 1-58
2016; 22, 4: 133-180
2016; 22, 3: 81-132
2016; 22, 2: 43-79
2016; 22, 1: 1-42
2015; 21, 4: 149-191
2015; 21, 3: 97-148
2015; 21, 2: 51-96
2015; 21, 1: 1-50
2014; 20, 4: 131-182
2014; 20, 3: 83-130
2014; 20, 2: 35-82